Interleukin‐6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease‐modifying antirheumatic drugs …

MC Genovese, JD McKay, EL Nasonov… - … : Official Journal of …, 2008 - Wiley Online Library
Objective To examine the efficacy and safety of the humanized anti–interleukin‐6 receptor
antibody tocilizumab combined with conventional disease‐modifying antirheumatic drugs …
被引用次数：1127 相关文章

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs …

MC Genovese, JD McKay… - Arthritis and …, 2008 - pubmed.ncbi.nlm.nih.gov
Objective To examine the efficacy and safety of the humanized anti-interleukin-6 receptor
antibody tocilizumab combined with conventional disease-modifying antirheumatic drugs …

Interleukin‐6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease‐modifying antirheumatic drugs …

MC Genovese, JD McKay, EL Nasonov… - … : Official Journal of …, 2008 - Wiley Online Library
Objective To examine the efficacy and safety of the humanized anti–interleukin‐6 receptor
antibody tocilizumab combined with conventional disease‐modifying antirheumatic drugs …

Interleukin‐6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease‐modifying antirheumatic drugs …

MC Genovese, JD McKay, EL Nasonov… - Arthritis & …, 2008 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Objective</jats: title>< jats: p> To
examine the efficacy and safety of the humanized anti–interleukin‐6 receptor antibody …

[引用][C] Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic …

MC Genovese, JD McKay, EL Nasonov… - Arthritis and …, 2008 - elibrary.ru

[引用][C] Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying …

MC GENOVESE, JD MCKAY… - Arthritis and …, 2008 - pascal-francis.inist.fr
Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid
Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The …

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs …

MC Genovese, JD McKay, EL Nasonov… - Arthritis and …, 2008 - europepmc.org
Objective To examine the efficacy and safety of the humanized anti-interleukin-6 receptor
antibody tocilizumab combined with conventional disease-modifying antirheumatic drugs …

[引用][C] Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic …

G MC - Arthritis Rheum., 2008 - cir.nii.ac.jp
Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis
with inadequate response to disease-modifying antirheumatic drugs | CiNii Research CiNii …